PLRZ
Polyrizon Ltd.
There isn't enough reported data to score PLRZ yet.
PLRZ Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
PLRZ's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
PLRZ PE Valuation
PLRZ has no meaningful PE right now: it lost money over the past year.
PLRZ Forward outlook
There aren't enough analyst estimates for PLRZ to show an outlook.
PLRZ Earnings Per Share
PLRZ Quarterly Revenue
PLRZ's revenue is shrinking: $0 last quarter.
PLRZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2M | -$2M |
| Q1 2026 | -$979K | -$978.1K |
| Q4 2025 | -$2.7M | -$1.9M |
| Q3 2025 | -$1.4M | -$1.4M |
| Q2 2025 | -$912 | +$336.1K |
| Q1 2025 | -$912 | -$744 |
| Q4 2024 | -$810K | -$608K |
| Q3 2024 | -$405 | +$100.6K |
PLRZ has burned cash in almost every quarter: −$7M over the past year, against −$812,229 the year before.
PLRZ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +13292% | +1.8M shares |
PLRZ has 2M diluted shares, up 13292% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
PLRZ hasn't bought back shares in the past year.
PLRZ Net Leverage
PLRZ's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PLRZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.9 | Neutral |
| Stochastic | 40.5 | Neutral |
PLRZ's weekly RSI is 44 (neutral) and its Stochastic is 40 (neutral).
PLRZ PE vs Healthcare Sector
| Metric | PLRZ | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PLRZ has no meaningful PE right now: it lost money over the past year.
PLRZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.2 | 13% above |
| 20 week MA | $11.4 | 0.5% above |
| 50 week MA | $12.5 | 8% below |
| 100 week MA | $308.4 | 96% below |
PLRZ has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 96% below its 100-week average.
PLRZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $1,755.0 | $2,460.0 | +40% |
| 2025 | $2,460.0 | $8.14 | -100% |
| 2026 YTD | $8.14 | $11.5 | +41% |
PLRZ is up 41% so far in 2026, after finishing lower in one of the previous two years.